vimarsana.com

Page 65 - ஆல்பர்ட் ஐன்ஸ்டீன் கல்லூரி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Betty Rhodes, Senior Corner: The importance of friendships

Blood plasma reduces risk of severe COVID-19 if given early

Katherine J Wu, The New York Times Published: 07 Jan 2021 12:00 PM BdST Updated: 07 Jan 2021 12:00 PM BdST A patient recovered from COVID-19 donated plasma at the Hemotherapy Institute in La Plata, Argentina, in October. Agustin Marcarian/Reuters A small but rigorous clinical trial in Argentina has found that blood plasma from recovered COVID-19 patients can keep older adults from getting seriously sick with the coronavirus if they get the therapy within days of the onset of the illness. ); } The results, published Wednesday in the New England Journal of Medicine, are some of the first to conclusively point toward the oft-discussed treatment’s beneficial effects. They arrive nearly five months after the Food and Drug Administration, under pressure from President Donald Trump, issued the therapy an emergency green light for use in people hospitalised with COVID-19.

Black people with type 1 diabetes, COVID-19 are four times more likely to be hospitalized for diabetic ketoacidosis

 E-Mail WASHINGTON Black and Hispanic people with COVID-19 and diabetes are more likely than Caucasians to die or have serious complications, according to a new study published in the Endocrine Society s Journal of Clinical Endocrinology & Metabolism. Health disparities refer to unequal health status or health care between groups of people due to differences in their background, physical traits or their environment. These differences include race/ethnicity, country of origin, sex, income and disability. Minorities are disproportionately affected by diabetes and COVID-19 and are more likely to develop serious complications like diabetic ketoacidosis, a condition that occurs when your body produces high levels of blood acids.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.